Evicenter
Wegovy (semaglutide) in Chronic weight management
Manufacturer
Novo Nordisk Inc.
Prescribing information
Wegovy (opens in a new tab)
Questions
61
Last updated

All questions

Clinical trials: Wegovy (semaglutide) in chronic weight management

17 questions · 4 sources

Study results

How much weight do people lose on Wegovy 2.4 mg (STEP 1)?

Applies to Chronic weight management in adults with obesity, or with overweight and at least one weight-related comorbid condition

Note: Study 2 of the Prescribing Information has the same design and enrollment (68 weeks, 1,961 patients randomized 2:1, type 2 diabetes excluded) as STEP 1 in the Clinical Product Review. Table 8 columns are placebo and WEGOVY injection for Study 2, then Study 3, then Study 4. Figure 2 of the Clinical Product Review gives the STEP 1 difference from placebo as -12.5%; Table 8 gives -12.4%.

Wegovy 2.4 mg: how many people lose 5%, 10%, 15%, or 20% of their weight?

Note: Each row gives placebo and WEGOVY injection for Study 2, then Study 3, then Study 4. Studies 2, 3, and 4 of the Prescribing Information have the same enrollment and design as STEP 1 (1,961 patients), STEP 2 (807 patients with type 2 diabetes), and STEP 3 (611 patients with intensive behavioral therapy) in the Clinical Product Review.

Wegovy in type 2 diabetes: how much weight do people lose (STEP 2)?

Applies to Weight reduction in adults with overweight or obesity and type 2 diabetes

Note: The second passage is the STEP 2 results paragraph, which opens page 6 of the Clinical Product Review.

Does Wegovy add weight loss to intensive behavioral therapy (STEP 3)?

Applies to Chronic weight management in adults with obesity, or with overweight and at least one weight-related comorbid condition

Do people regain weight after stopping Wegovy (STEP 4)?

Applies to Chronic weight management in adults with obesity, or with overweight and at least one weight-related comorbid condition

Note: STEP 4 is a randomized withdrawal trial: only patients who reached the 2.4 mg dose during the 20-week run-in were randomized to continue Wegovy or switch to placebo. Study 5 of the Prescribing Information has the same design and enrollment (902 enrolled, 803 randomized after a 20-week run-in) as STEP 4 in the Clinical Product Review. In the Table 9 rows, the first value is placebo and the second is WEGOVY injection.

How much weight do people lose on Wegovy 2.4 mg over 2 years (STEP 5)?

Applies to Chronic weight management in adults with obesity, or with overweight and at least one weight-related comorbid condition

Note: STEP 5 results are from the chronic weight management page of the Wegovy HCP site and the Clinical Product Review, which cite Garvey et al., Nat Med 2022; the Wegovy Prescribing Information does not describe this trial.

How much weight do East Asian adults lose on Wegovy (STEP 6)?

Applies to Chronic weight management in adults with obesity, or with overweight and at least one weight-related comorbid condition

How much weight do people lose on Wegovy HD 7.2 mg (STEP UP)?

Applies to Weight reduction in adults with obesity with the 7.2 mg once-weekly dose (Wegovy HD)

Note: Wegovy HD is the 7.2 mg once-weekly dose of Wegovy injection. The first set of results is the treatment regimen estimand (all randomized patients) and the second the efficacy estimand (if all patients had stayed on treatment).

Does Wegovy 7.2 mg cause more weight loss than Wegovy 2.4 mg?

Applies to Weight reduction in adults with obesity with the 7.2 mg once-weekly dose (Wegovy HD)

Note: Table 12 columns are placebo, WEGOVY 2.4 mg, and WEGOVY 7.2 mg for Study 8 (patients with obesity), then the same three arms for Study 9 (type 2 diabetes with obesity). Study 8 has the same design and enrollment (72 weeks, 1,407 patients randomized 5:1:1) as STEP UP on the Wegovy HCP site.

Wegovy HD: how many people lose 10%, 15%, 20%, or 25% of their weight?

Applies to Weight reduction in adults with obesity with the 7.2 mg once-weekly dose (Wegovy HD)

Note: These are STEP UP results (Wegovy HD 7.2 mg vs placebo at 72 weeks in adults with obesity). The 10%, 15%, and 20% proportions are treatment regimen estimand results; the 25% proportions are observed data.

Wegovy 7.2 mg in type 2 diabetes: how much weight do people lose?

Applies to Weight reduction in adults with overweight or obesity and type 2 diabetes

Note: In the Table 12 rows, the last three columns are Study 9: placebo, WEGOVY 2.4 mg, and WEGOVY 7.2 mg.

How much weight do people lose on the Wegovy pill (OASIS 4)?

Applies to Chronic weight management in adults with obesity, or with overweight and at least one weight-related comorbid condition, with Wegovy tablets (pill)

Note: The Wegovy pill is Wegovy (semaglutide) 25 mg tablets taken once daily. Study 7 of the Prescribing Information has the same design and enrollment (64 weeks, 307 patients randomized 2:1) as OASIS 4. In the Table 11 rows, the first value is placebo and the second is WEGOVY 25 mg tablets.

Wegovy pill: how many people lose 10%, 15%, or 20% of their weight?

Applies to Chronic weight management in adults with obesity, or with overweight and at least one weight-related comorbid condition, with Wegovy tablets (pill)

Note: These are OASIS 4 results for Wegovy 25 mg tablets vs placebo at 64 weeks in adults with obesity, or with overweight and at least one weight-related comorbidity, without type 2 diabetes. In the Table 11 row from the Prescribing Information (Study 7), the first value is placebo and the second is WEGOVY 25 mg tablets.

Were the Wegovy pill doses in OASIS 4 the approved doses?

Applies to Chronic weight management in adults with obesity, or with overweight and at least one weight-related comorbid condition, with Wegovy tablets (pill)

How long does Wegovy take to start working?

Applies to Chronic weight management in adults with obesity, or with overweight and at least one weight-related comorbid condition

Does Wegovy lower blood pressure, cholesterol, and triglycerides?

Applies to Chronic weight management in adults with obesity, or with overweight and at least one weight-related comorbid condition

Note: These values are STEP 5 results for Wegovy 2.4 mg vs placebo from baseline to week 104 in adults with obesity, or with overweight and at least one weight-related comorbidity. STEP 5 is not described in the Wegovy Prescribing Information.

Pill vs injection

Is the Wegovy pill as effective as the Wegovy injection?

Applies to Chronic weight management in adults with obesity, or with overweight and at least one weight-related comorbid condition, with Wegovy tablets (pill)